Literature DB >> 8710742

Diffusivity of bile salt/phospholipid aggregates in mucin.

C Y Li1, C L Zimmerman, T S Wiedmann.   

Abstract

PURPOSE: The objective of this study is to evaluate the effect of the mucous layer on the transport of the drug-solubilizing bile salt/phosphatidylcholine (BS/PC) aggregates.
METHODS: The self-diffusion coefficient of BS/PC aggregates in bovine submaxillary mucin (BSM) was measured by Fourier-transform pulsed-field gradient spin-echo (FT-PGSE) 1H NMR spectroscopy.
RESULTS: In spite of the complexity of the mixture, the FT-PGSE technique allowed the unambiguous determination of the diffusivity of PC and 1H2HO (HDO, natural abundance in D2O). With a series of BS/PC total lipid concentrations ranging from 1 to 7 g/dl, a progressive decrease in the effective diffusivity of HDO was observed with an increase in the both the BSM and total lipid concentration. The effective diffusivity of PC decreased with increasing lipid concentrations in the presence of mucin, while in the controls it increased. After correcting the effective diffusivity of PC for the obstruction effect of mucin, the size of the BS/PC mixed micelle was assessed. It appears that PC associates with BSM resulting in a decrease in the available PC for micellization. This reduces the average size of the mixed micelle within the mucous layer.
CONCLUSIONS: The aggregation state of BS/PC micelle is altered by the presence of mucin which would have a direct impact on the transport of dietary lipid and solubilized drug through the aqueous boundary layer of the intestinal tract.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710742     DOI: 10.1023/a:1016085719058

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Micelle formation and testosterone solubilization by sodium glycocholate.

Authors:  L Martis; N A Hall; A L Thakkar
Journal:  J Pharm Sci       Date:  1972-11       Impact factor: 3.534

2.  Diffusion in HPMC gels. II. Prediction of drug release rates from hydrophilic matrix extended-release dosage forms.

Authors:  P Gao; P R Nixon; J W Skoug
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

Review 3.  Structure and function of mucus.

Authors:  A Silberberg; F A Meyer
Journal:  Adv Exp Med Biol       Date:  1982       Impact factor: 2.622

4.  Lipids associated with dog gastric mucus glycoprotein.

Authors:  H Witas; B L Slomiany; E Zdebska; K Kojima; Y H Liau; A Slomiany
Journal:  J Appl Biochem       Date:  1983 Feb-Apr

5.  One- and two-dimensional NMR relaxation studies of dynamics and structure in bile salt-phosphatidylcholine mixed micelles.

Authors:  R E Stark; R W Storrs; S E Levine; S Yee; M S Broido
Journal:  Biochim Biophys Acta       Date:  1986-08-21

6.  Solubilization and wetting effects of bile salts on the dissolution of steroids.

Authors:  V Bakatselou; R C Oppenheim; J B Dressman
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

7.  Hydrophobic binding properties of bovine gallbladder mucin.

Authors:  B F Smith; J T LaMont
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

8.  Lipids associated with rat small-intestinal mucus glycoprotein.

Authors:  H Witas; J Sarosiek; M Aono; V L Murty; A Slomiany; B L Slomiany
Journal:  Carbohydr Res       Date:  1983-08-16       Impact factor: 2.104

9.  Quasielastic light-scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions.

Authors:  N A Mazer; G B Benedek; M C Carey
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

10.  Most of the lipid in purulent sputum is bound to mucus glycoprotein.

Authors:  C E Nadziejko; B L Slomiany; A Slomiany
Journal:  Exp Lung Res       Date:  1993 Nov-Dec       Impact factor: 2.459

View more
  9 in total

1.  Distribution and diffusion of sodium taurocholate and egg phosphatidylcholine aggregates in rat intestinal mucin.

Authors:  T S Wiedmann; H Herrington; C Deye; D Kallick
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

2.  Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux.

Authors:  David Meriwether; Dawoud Sulaiman; Alan Wagner; Victor Grijalva; Izumi Kaji; Kevin J Williams; Liqing Yu; Spencer Fogelman; Carmen Volpe; Steven J Bensinger; G M Anantharamaiah; Ishaiahu Shechter; Alan M Fogelman; Srinivasa T Reddy
Journal:  J Lipid Res       Date:  2016-05-19       Impact factor: 5.922

3.  Lipid absorption triggers drug supersaturation at the intestinal unstirred water layer and promotes drug absorption from mixed micelles.

Authors:  Yan Yan Yeap; Natalie L Trevaskis; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-06-21       Impact factor: 4.200

4.  Intestinal mucus is capable of stabilizing supersaturation of poorly water-soluble drugs.

Authors:  Yan Yan Yeap; Jaclyn Lock; Sean Lerkvikarn; Tanner Semin; Nicholas Nguyen; Rebecca L Carrier
Journal:  J Control Release       Date:  2018-12-06       Impact factor: 9.776

5.  Ionization and solubilization of 4 alkyl benzoic acids and 4 alkyl anilines in sodium taurodeoxycholate solutions.

Authors:  T S Wiedmann; K Kvanbeck; C H Han; V Roongta
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

6.  Interaction of bile salt and phospholipids with bovine submaxillary mucin.

Authors:  T S Wiedmann; C Deye; D Kallick
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

7.  Interaction of bile salts with gastrointestinal mucins.

Authors:  Timothy Scott Wiedmann; Wei Liang; Heather Herrington
Journal:  Lipids       Date:  2004-01       Impact factor: 1.880

8.  Interaction of a self-emulsifying lipid drug delivery system with the everted rat intestinal mucosa as a function of droplet size and surface charge.

Authors:  T Gershanik; S Benzeno; S Benita
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

9.  Solubilization of retinoids by bile salt/phospholipid aggregates.

Authors:  C Y Li; C L Zimmerman; T S Wiedmann
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.